Thoratec Corporation: Thoratec Reports Second Quarter 2014 Results

Posted by Unknown on Wednesday, August 6, 2014

... both HeartMate III and HeartMate PHP, while HeartMate III also received conditional approval from FDA to begin the U.S. trial," Burbach commented.

more

{ 0 comments... » Thoratec Corporation: Thoratec Reports Second Quarter 2014 Results read them below or add one }

Post a Comment

Popular Posts